92166-40-0Relevant articles and documents
A highly selective diarylethene fluorescence sensor of aluminum ion and its application
Fan, Congbin,Liu, Gang,Pu, Shouzhi,Wang, Huaxin,Zhao, Heng
, (2020/10/18)
A novel diarylethene derivative 1O with the unit of N-(2-(hydrazinecarbonyl)phenyl)benzamide was designed and synthesized successfully. The sensor showed excellent photochromism and specific fluorescent detection toward aluminum ion with rarely interfering. The emission intensity could increase nearly by 100 folds with aluminum ion and the color changed from dark to Aqua green. The low limit of detection (LOD) of 1O was determined as 3.26 × 10-8 mol L-1. Additionally, the sensor could be used in logic circuit and aluminum ion detection in untreated water.
Design, synthesis, crystal structure, in vitro cytotoxicity evaluation, density functional theory calculations and docking studies of 2-(benzamido) benzohydrazide derivatives as potent AChE and BChE inhibitors
Altaf, Ataf Ali,Arshad, Muhammad Nadeem,Asiri, Abdullah M.,El-Bahy, Salah M.,Elnaggar, Ashraf Y.,Kausar, Naghmana,Kausar, Samia,Murtaza, Shahzad,Tatheer, Adina,Zaib Saleem, Rahman Shah
, p. 154 - 167 (2022/01/19)
A series of hydrazone derivatives of 2-(benzamido) benzohydrazide was designed, synthesized, and characterized utilizing FTIR, NMR and UV spectroscopic techniques along with mass spectrometry. Compound 10 was also characterized through X-ray crystallograp
A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition
Nasli-Esfahani, Ensieh,Mohammadi-Khanaposhtani, Maryam,Rezaei, Sepideh,Sarrafi, Yaghoub,Sharafi, Zeinab,Samadi, Nasser,Faramarzi, Mohammad Ali,Bandarian, Fatemeh,Hamedifar, Haleh,Larijani, Bagher,Hajimiri, Mirhamed,Mahdavi, Mohammad
, (2019/08/12)
A series of new Schiff bases bearing 1,2,3-triazole 12a?o was designed, synthesized, and evaluated as α-glucosidase inhibitors. All the synthesized compounds showed promising inhibition against α-glucosidase and were more potent than the standard drug aca